loader
Suraksha Clinic and Diagnostic IPO
Issue Size (Net)
up to Rs.846.25 Cr
Price Band
Rs.420 to Rs.441 per share
Issue Opens
November 29, 2024
Issue Closes
December 3, 2024

Company Highlights

1.Company Information

Incorporated in 2005, Suraksha Diagnostic Limited offers pathology, radiology testing and medical consultancy services. The company has a central reference laboratory with 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres as of June 30, 2024, across West Bengal, Bihar, Assam, and Meghalaya. The company offers its customers online and offline medical consultation services under one roof via 44 diagnostic centres, which house 120 polyclinics with more than 750 doctors. The operation of the diagnostic centres is supported by the technology platforms and systems that the company uses to streamline, such as its Laboratory Information Management System ("LIMS"), its fully integrated Radiology Information System ("RIS"), its Picture Archive Communication System ("PACS") and its Enterprise Resource Planning System ("ERP"). The company offers vaccination services and customized testing packages for disease prediction/early detection. The company uses digital pathology and artificial intelligence to generate blood tests. All radiology reporting is done through a digital platform that allows cases to be reported from all diagnostic centres, significantly reducing turnaround time.

Competitive Strengths are:

Well-positioned diagnostics chain to capture the large growth opportunities for organized diagnostics chains in the fragmented markets for diagnostic services in eastern and northeastern India.
Integrated diagnostics provider offering pathology and radiology testing and medical consultancy services from a single source.
Well-invested and technologically advanced clinical infrastructure.
Commitment to quality driving high individual consumer business share and customer retention.
Management team with relevant industry experience.

2. Objects of the Issue Suraksha Diagnostic Limited IPO Objectives)

The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.

3. Suraksha Diagnostic Limited IPO Registrar
Kfin Technologies Limited

Phone: 04067162222, 04079611000

Email: sdl.ipo@kfintech.com

Website:  https://kosmic.kfintech.com/ipostatus/

Suraksha Diagnostic Limited IPO Financial Information (Restated)

Period Ended
Total Assets
Total Revenue
Profit After Tax
Net Worth
Reserves and Surplus
Total Borrowing
30-Jun-24
314.2
61.85
7.67
187.05
176.8
7.57
31-Mar-24
300.21
222.26
23.13
179.41
170.88
8.64
31-Mar-23
281.2
193.69
6.07
155.93
147.4
14.01
Amount in Rs.Crore

Suraksha Clinic and Diagnostic IPO Details

Issue Opening Date
November 29, 2024
Issue Closing Date
December 3, 2024
Face Value
Rs.2 per share
Price
Rs.420 to Rs.441 per share
Lot Size
34 Shares
Issue Size
19,189,330 shares(aggregating up to Rs.846.25 Cr)
Offer for Sale
19,189,330 shares of Rs.2(aggregating up to Rs.846.25 Cr)
Issue Type
Book Built Issue IPO
Listing At
BSE, NSE
Share holding pre issue
52,080,758
Share holding post issue
8,425,925,926

Suraksha Diagnostic Limited IPO Timeline (Tentative Schedule)

Event
Tentative Date
Opening Date
Friday, November 29, 2024
Closing Date
Tuesday, December 3, 2024
Basis of Allotment
Wednesday, December 4, 2024
Initiation of Refunds
Thursday, December 5, 2024
Credit of Shares to Demat
Thursday, December 5, 2024
Listing Date
Friday, December 6, 2024
Cut-off time for UPI mandate confirmation
5 PM on December 3, 2024

Prospectus

Prospectus File

RR Investors Capital Services Pvt. Ltd AMFI-registered Mutual Fund Distributor

ARN-0032 Validity 14-Mar-2027

Head Office - 4th floor, Indraprakash Building 21, Barakhamba Road, New Delhi – 110001

callLandline Number
+91 11-4444-1111

Customer Care
+91 9350316010

Security
  • SSL
Follow Us

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508


* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.


© 2022 RR Investors Capital Services Pvt. Ltd | All Rights Reserved.